COVID-19 challenges in clinical trials


  • Murugan Panchatcharam Amaris Clinical; Division of Caplin Point Laboratories Limited, Chennai, Tamil Nadu, India
  • Sravanthi Lakshmi Mukku Amaris Clinical; Division of Caplin Point Laboratories Limited, Chennai, Tamil Nadu, India



Antioxidant enzymes, Atherogenicity, Coconut oil, Glucose tolerance


Clinical research involves working with human subjects to answer questions relevant to their well-being in an ethical manner. The current scenario from the past one year has drastically changed the face of the clinical trials. The present COVID prevalence and simultaneously conducting the research with all the regulations and the precautions has been the difficult task for the contract research organisations (CRO).


Current clinical trials. Available at: https:// Accessed on 20 February 2021.

DeVito NJ, Bacon S, Goldacre B. Compliance with legal requirement to report clinical trial results on a cohort study. Lancet. 2020;395 (10221):361-9.

FDA guidance on conduct of clinical trials of medical products during COVID-19 public health emergency. Available at: download. Accessed on 20 February 2021.

Cinical trial reporting. Available at: Accessed on 20 February 2021.

Public disclosure of clinical trial results. Available at: Statement_results_reporting_clinical_trials.pdf. Accessed on 20 February 2021.

Anderson ML, Chiswell K, Peterson ED, Tasneem A, Topping J, Califf RM. Compliance with results reporting at N Engl J Med. 2015; 372:1031-9.

World medical association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191-4.

Bagiella E, Bhatt DL, Gaudino M. The consequences of the COVID-19 pandemic on non-COVID-19 clinical trials. J Am Coll Cardiol. 2020;76:342-5.

Coronavirus in the US: latest map and case count. Available at: Accessed on 13 May 2020.




How to Cite

Panchatcharam, M., & Mukku, S. L. (2021). COVID-19 challenges in clinical trials. International Journal of Basic & Clinical Pharmacology, 10(6), 769–769.



Letter to the Editor